Sino Biopharmaceutical | 1177 - Ebitda

Aktienkurs
5.98
Täglich Wechseln
-0.08 -1.32%
Monatlich
-12.57%
Jährlich
66.11%
Q1 Prognose
5.72




Ebitda Veränderung Datum
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
Avita Medical AUD -9.69M 12.21M 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Dianthus Therapeutics USD -40.19M 5.36M 2025-09
Ionis Pharmaceuticals USD -157.12M 307.36M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Jiangsu Hengrui CNY 2.98B 890.87M 2025-06
Moderna USD -790M 582M 2025-12
Organon & Co USD 383M 135M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tectonic Therapeutic USD -21.18M 365K 2025-12
Viatris USD 1B 151.5M 2025-12
Xeris Pharmaceuticals USD 25.09M 7.67M 2025-12